NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
1,393.1%
Industry median - (122.4%)
5Y Historical average - (1,246.0%)
1,382.4%
Industry median - (129.8%)
5Y Historical average - (1,255.4%)
31.8%
Industry median - (52.2%)
5Y Historical average - (22.5%)
26.7%
Industry median - (51.2%)
5Y Historical average - (33.8%)
PTGX Capital Allocation Rating
Crunching data... Almost there!
PTGX Capital Allocation metrics
Crunching data... Almost there!
Competing with PTGX Capital Allocation
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) ROIC (Return on Invested Capital)?
The Protagonist Therapeutics, Inc. (PTGX) ROIC is 1,393.1%, compared to the industry median of ((122.4%)) and the 5-year historical average of (1,246.0%).
What is the Protagonist Therapeutics, Inc. (PTGX) ROIC minus WACC (Weighted Average Cost of Capital)?
The Protagonist Therapeutics, Inc. (PTGX) ROIC minus WACC is 1,382.4%, compared to the industry median of ((129.8%)) and the 5-year historical average of (1,255.4%).
What is the Protagonist Therapeutics, Inc. (PTGX) ROE (Return on Equity)?
The Protagonist Therapeutics, Inc. (PTGX) ROE is 31.8%, compared to the industry median of ((52.2%)) and the 5-year historical average of (22.5%).
What is the Protagonist Therapeutics, Inc. (PTGX) ROCE (Return on Capital Employed)?
The Protagonist Therapeutics, Inc. (PTGX) ROCE is 26.7%, compared to the industry median of ((51.2%)) and the 5-year historical average of (33.8%).